MedTrace Logo

Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)

NCT03407755 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2019-02-15

No results posted yet for this study

Summary

This blinded, randomized study compares the use of air and sulfur hexaflouride (SF6) tamponade in Descemet Membrane Endothelial Keratoplasty.

Conditions

  • Fuchs' Endothelial Dystrophy
  • Bullous Keratopathy

Interventions

PROCEDURE

Intraocular gas

Participants randomized to either air or SF6 gas in the anterior chamber.

Sponsors & Collaborators

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Mark Alberti, MD · Rigshospitalet - Glostrup

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2019-12-31
Completion
2020-05-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03407755 on ClinicalTrials.gov